ARTICLE | Company News
Amoun, Valeant Pharmaceuticals deal
August 10, 2015 7:00 AM UTC
Valeant will acquire Amoun for $800 million. Amoun markets antihypertensives, broad-spectrum antibiotics and antidiarrheals. Valeant plans to use the acquisition to expand into the Middle East and Nor...